What We Do

Pagoda Genomics is at the forefront of a revolution in protective skincare products. Our patent-protected technology platform and direct-to-market strategy set us apart.

Our Mission: Develop the next generation of skincare products that work with our skin microbiome to protect us from infectious diseases.

Infectious diseases caused by bacteria and viruses are often transmitted through contact between individuals, or contact between an individual and a contaminated surface. Handwashing, hand sanitizers, and disinfectants can prevent infection; however, they only provide transient protection, until the next encounter with an infectious individual or surface. Although critical in treating infection, the indiscriminate use of antibiotics, antimicrobials, and antivirals over the last nine decades has led to multi-drug resistance and the resurgence of diseases that had been consigned to medical history.

To address this unmet need, we have developed a technology that utilizes antimicrobial proteins to target specific bacteria and viruses, which are incorporated into a formulation that can be applied to the skin or other surfaces. These products provide long-lasting, durable protection from bacteria and viruses and help to prevent infection and transmission.

Antimicrobial proteins have been demonstrated to be effective in many successful products, however, to date, the external use of antimicrobial proteins to neutralize disease-causing agents has not been explored and remains an area of great potential.